![Karen Massey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Massey
Algemeen Directeur bij
ARGENX SE
Vermogen: 4 M $ op 31-05-2026
Profiel
Karen Massey is currently Chief Executive Officer & Executive Director at argenx SE, starting in 2026.
Former positions include Senior Vice President-Product Development at Genentech, Inc. and Principal at Pfizer Inc. Education includes an undergraduate degree from The University of Sydney and an MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARGENX SE 0,01% | 06-05-2026 | 4.392 ( 0,01% ) | 4 M $ | 31-05-2026 |
Laatste nieuws over Karen Massey
| 05/01 | Argenx in het rood in vlakke Bel20 | AM |
| 05/01 | Nieuwe CEO Argenx sterke keuze | AM |
| 05/01 | Groene start voor Bel20 | AM |
| 05/01 | Karen Massey aangesteld als volgende CEO van argenx |  |
Actieve functies van Karen Massey
| Bedrijven | Functie | Begin |
|---|---|---|
| ARGENX SE | Algemeen Directeur | 06-05-2026 |
Eerdere bekende functies van Karen Massey
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Opleiding van Karen Massey
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
